Related Experiment Videos
Predictors of death from congestive heart failure in hypertrophic cardiomyopathy
1Department of Internal Medicine III and Cardiovascular Research Institute, Kurume University School of Medicine, Japan. ikeikeda@med.kurume-u.ac.jp
Insights
Smaller electrocardiographic and echocardiographic measurements predict heart failure death in hypertrophic cardiomyopathy patients. These findings aid in developing strategies to prevent fatal heart failure in this population.
Area of Science:
- Cardiology
- Clinical Medicine
- Heart Disease Research
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant cause of heart failure.
- Identifying predictors of mortality in HCM is crucial for patient management.
Purpose of the Study:
- To identify independent predictors of death from congestive heart failure in patients with HCM.
- To inform the development of preventative therapeutic strategies.
Main Methods:
- Long-term follow-up of 309 patients diagnosed with hypertrophic cardiomyopathy.
- Analysis of electrocardiographic (ECG) parameters, specifically SV1 + RV5.
- Assessment of echocardiographic fractional shortening.
Main Results:
- Smaller initial electrocardiographic SV1 + RV5 values were associated with increased risk of heart failure death.
- Smaller initial echocardiographic fractional shortening was also an independent predictor of heart failure death.
- Fifteen deaths from congestive heart failure were recorded during the mean 9.4-year follow-up.
Conclusions:
- Initial ECG and echocardiographic findings can predict fatal heart failure in HCM patients.
- These predictors can guide targeted interventions to improve outcomes.
- Further research can refine therapeutic strategies for preventing heart failure mortality in HCM.
Abstract:
In 309 patients with hypertrophic cardiomyopathy during long-term follow-up (mean 9.4 years), independent predictors of death from congestive heart failure (n = 15) were smaller electrocardiographic SV1 + RV5 and smaller echocardiographic fractional shortening at the initial evaluation. Our data may contribute to the construction of therapeutic strategies for the prevention of heart failure death in patients with hypertrophic cardiomyopathy.